{"id":81483,"date":"2024-11-23T09:04:10","date_gmt":"2024-11-23T12:04:10","guid":{"rendered":"https:\/\/portalnpm.com\/?p=81483"},"modified":"2024-11-23T09:04:10","modified_gmt":"2024-11-23T12:04:10","slug":"anvisa-atualiza-composicao-de-vacinas-contra-covid-19","status":"publish","type":"post","link":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/","title":{"rendered":"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19"},"content":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta sexta-feira (22) a atualiza\u00e7\u00e3o da composi\u00e7\u00e3o das vacinas Spikevax, da farmac\u00eautica Adium, e Comirnaty, da Pfizer. Ambas s\u00e3o utilizadas no Brasil para a preven\u00e7\u00e3o da covid-19.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1620958&amp;o=node\" \/><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1620958&amp;o=node\" \/><\/p>\n<p>A atualiza\u00e7\u00e3o consiste na altera\u00e7\u00e3o da cepa usada na produ\u00e7\u00e3o do imunizante e atende a normas rec\u00e9m-publicadas pela pr\u00f3pria Anvisa. As doses devem ser atualizadas periodicamente, de modo a conter as cepas recomendadas pela Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS), como j\u00e1 acontece com a composi\u00e7\u00e3o da vacina contra a influenza.<\/p>\n<p>Em nota, a Anvisa destacou que a OMS trabalha no monitoramento das variantes do v\u00edrus da covid em circula\u00e7\u00e3o no mundo e na verifica\u00e7\u00e3o da manuten\u00e7\u00e3o da efic\u00e1cia das vacinas dispon\u00edveis. \u201cSua \u00faltima recomenda\u00e7\u00e3o foi publicada em 26 de abril deste ano, quando informou sobre a necessidade de atualiza\u00e7\u00e3o dos imunizantes para a cepa JN.1\u201d.<\/p>\n<p>De acordo com a ag\u00eancia, o Brasil conta atualmente com tr\u00eas vacinas monovalentes aprovadas para a preven\u00e7\u00e3o da covid-19, mas apenas a Spikevax e a Comirnaty solicitaram a atualiza\u00e7\u00e3o \u00e0 entidade.<\/p>\n<p>\u201cEm setembro deste ano, a Anvisa priorizou a an\u00e1lise de dados e provas apresentados pelas empresas, por se tratar de imunizantes previstos no Programa Nacional de Imuniza\u00e7\u00f5es (PNI) do Minist\u00e9rio da Sa\u00fade.\u201d<\/p>\n<h2>Indica\u00e7\u00e3o<\/h2>\n<p>A indica\u00e7\u00e3o das duas vacinas em quest\u00e3o segue sendo a mesma de seus respectivos registros: para uso em indiv\u00edduos a partir de 6 meses de idade. J\u00e1 o esquema posol\u00f3gico varia de acordo com o produto a ser administrado, a idade do paciente e seu esquema de vacina\u00e7\u00e3o pr\u00e9via.<\/p>\n<p>Para mais informa\u00e7\u00f5es, a Anvisa orienta que sejam consultadas as bulas da <a href=\"https:\/\/consultas.anvisa.gov.br\/#\/bulario\/q\/?nomeProduto=Spikevax\" target=\"_blank\" rel=\"noopener\">Spikevax<\/a> e da <a href=\"https:\/\/consultas.anvisa.gov.br\/#\/bulario\/q\/?nomeProduto=comirnaty\" target=\"_blank\" rel=\"noopener\">Comirnarty<\/a>, dispon\u00edveis no Bul\u00e1rio Eletr\u00f4nico da Anvisa.<\/p>\n<p><strong>Fonte<\/strong>: Ag\u00eancia Brasil<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta sexta-feira (22) a atualiza\u00e7\u00e3o da composi\u00e7\u00e3o das vacinas Spikevax, da farmac\u00eautica Adium, e Comirnaty, da Pfizer. Ambas s\u00e3o utilizadas no Brasil para a preven\u00e7\u00e3o da covid-19. A atualiza\u00e7\u00e3o consiste na altera\u00e7\u00e3o da cepa usada na produ\u00e7\u00e3o do imunizante e atende a normas rec\u00e9m-publicadas pela pr\u00f3pria Anvisa. &hellip;<\/p>\n","protected":false},"author":8,"featured_media":81484,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"yes","rop_publish_now_accounts":{"facebook_2648258775420054_1618374048415101":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[384],"tags":[434,5487,16030,550,350,230,2723],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta sexta-feira (22) a atualiza\u00e7\u00e3o da composi\u00e7\u00e3o das vacinas Spikevax, da farmac\u00eautica Adium, e Comirnaty, da Pfizer. Ambas s\u00e3o utilizadas no Brasil para a preven\u00e7\u00e3o da covid-19. A atualiza\u00e7\u00e3o consiste na altera\u00e7\u00e3o da cepa usada na produ\u00e7\u00e3o do imunizante e atende a normas rec\u00e9m-publicadas pela pr\u00f3pria Anvisa. &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal NPM\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-23T12:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Zenilton Lima\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zenilton Lima\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/\",\"url\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/\",\"name\":\"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM\",\"isPartOf\":{\"@id\":\"https:\/\/portalnpm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp\",\"datePublished\":\"2024-11-23T12:04:10+00:00\",\"dateModified\":\"2024-11-23T12:04:10+00:00\",\"author\":{\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e\"},\"breadcrumb\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp\",\"width\":1170,\"height\":700,\"caption\":\"SESA\/GOV. ESTADO PARAN\u00c1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/portalnpm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/portalnpm.com\/#website\",\"url\":\"https:\/\/portalnpm.com\/\",\"name\":\"Portal NPM\",\"description\":\"Not\u00edcias em Primeira M\u00e3o\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/portalnpm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e\",\"name\":\"Zenilton Lima\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg\",\"caption\":\"Zenilton Lima\"},\"url\":\"https:\/\/portalnpm.com\/index.php\/author\/zenilton\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta sexta-feira (22) a atualiza\u00e7\u00e3o da composi\u00e7\u00e3o das vacinas Spikevax, da farmac\u00eautica Adium, e Comirnaty, da Pfizer. Ambas s\u00e3o utilizadas no Brasil para a preven\u00e7\u00e3o da covid-19. A atualiza\u00e7\u00e3o consiste na altera\u00e7\u00e3o da cepa usada na produ\u00e7\u00e3o do imunizante e atende a normas rec\u00e9m-publicadas pela pr\u00f3pria Anvisa. &hellip;","og_url":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/","og_site_name":"Portal NPM","article_published_time":"2024-11-23T12:04:10+00:00","og_image":[{"width":1170,"height":700,"url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp","type":"image\/webp"}],"author":"Zenilton Lima","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Zenilton Lima","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/","url":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/","name":"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19 - Portal NPM","isPartOf":{"@id":"https:\/\/portalnpm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp","datePublished":"2024-11-23T12:04:10+00:00","dateModified":"2024-11-23T12:04:10+00:00","author":{"@id":"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e"},"breadcrumb":{"@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#primaryimage","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp","width":1170,"height":700,"caption":"SESA\/GOV. ESTADO PARAN\u00c1"},{"@type":"BreadcrumbList","@id":"https:\/\/portalnpm.com\/index.php\/2024\/11\/23\/anvisa-atualiza-composicao-de-vacinas-contra-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/portalnpm.com\/"},{"@type":"ListItem","position":2,"name":"Anvisa atualiza composi\u00e7\u00e3o de vacinas contra covid-19"}]},{"@type":"WebSite","@id":"https:\/\/portalnpm.com\/#website","url":"https:\/\/portalnpm.com\/","name":"Portal NPM","description":"Not\u00edcias em Primeira M\u00e3o","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/portalnpm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e","name":"Zenilton Lima","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/image\/","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg","caption":"Zenilton Lima"},"url":"https:\/\/portalnpm.com\/index.php\/author\/zenilton\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/11\/IMG_4990.webp","_links":{"self":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/81483"}],"collection":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/comments?post=81483"}],"version-history":[{"count":1,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/81483\/revisions"}],"predecessor-version":[{"id":81485,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/81483\/revisions\/81485"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media\/81484"}],"wp:attachment":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media?parent=81483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/categories?post=81483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/tags?post=81483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}